Edgewise Therapeutics Inc’s recent filing unveils that its General Counsel MOORE JOHN R unloaded Company’s shares for reported $0.16 million on Feb 09 ’24. In the deal valued at $20.01 per share,8,029 shares were sold. As a result of this transaction, MOORE JOHN R now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Derakhshan Behrad sold 4,800 shares, generating $96,209 in total proceeds. Upon selling the shares at $20.04, the Chief Business Officer now owns 7,020 shares.
Before that, Derakhshan Behrad sold 4,600 shares. Edgewise Therapeutics Inc shares valued at $92,049 were divested by the Chief Business Officer at a price of $20.01 per share. As a result of the transaction, Derakhshan Behrad now holds 7,020 shares, worth roughly $0.12 million.
Piper Sandler initiated its Edgewise Therapeutics Inc [EWTX] rating to an Overweight in a research note published on March 07, 2024; the price target was $48. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. Goldman also remained covering EWTX and has decreased its forecast on August 25, 2022 with a “Sell” recommendation from previously “Neutral” rating. RBC Capital Mkts started covering the stock on April 13, 2022. It rated EWTX as “an Outperform”.
Price Performance Review of EWTX
On Tuesday, Edgewise Therapeutics Inc [NASDAQ:EWTX] saw its stock jump 7.12% to $17.14. Over the last five days, the stock has gained 5.87%. Edgewise Therapeutics Inc shares have risen nearly 56.67% since the year began. Nevertheless, the stocks have risen 149.49% over the past one year. While a 52-week high of $20.69 was reached on 02/09/24, a 52-week low of $5.12 was recorded on 01/17/24. SMA at 50 days reached $16.80, while 200 days put it at $9.64. A total of 0.68 million shares were traded, compared to the trading of 0.52 million shares in the previous session.
Levels Of Support And Resistance For EWTX Stock
The 24-hour chart illustrates a support level at 16.31, which if violated will result in even more drops to 15.48. On the upside, there is a resistance level at 17.76. A further resistance level may holdings at 18.39. The Relative Strength Index (RSI) on the 14-day chart is 53.15, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.36, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.84%. Stochastics %K at 35.15% indicates the stock is a holding.
How much short interest is there in Edgewise Therapeutics Inc?
A steep rise in short interest was recorded in Edgewise Therapeutics Inc stocks on Feb 29, 2024, growing by 60000.0 shares to a total of 5.46 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 5.4 million shares. There was a rise of 1.1%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 9.88% of the overall stock float, the days-to-cover ratio (short ratio) rose to 7.24.
The most recent change occurred on January 28, 2022 when Goldman began covering the stock and recommended ‘”a Neutral”‘ rating along with a $11 price target.
